encorafenib,binimetinib
pfizer,pierre fabre,ono pharma
['encorafenib', 'binimetinib', 'lung']
phase ii, open-label study of encorafenib plus binimetinib in patients with brafv600-mutant metastatic non small-cell lung cancer #asco23 #asco2023 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News